CPL develops, manufactures, packages, and tests non-sterile liquid and semi-solid pharmaceutical products. We are solely focused on these dosage forms, and it’s this focus that has earned us our reputation as an industry leader, perfecting our capabilities in each of these areas.
Our facilities are registered with the U.S. FDA, Health Canada, and the Japanese Health Authority, and are well-equipped to support a multitude of products including NDAs, ANDAs, and OTCs, among others. These and other international agencies routinely inspect our facilities through GMP or Pre-Approval Inspections, and our compliance team regularly hosts routine audits with current and prospective customers.
Our product development team consists of more than 50 people with 175 collective years of formulation development and analytical experience combined. This team strives to find the balance between scientific rigor and short, efficient timelines.